Promising stem cell trial results
Three year results from a five year study show promising results. 24 people with active relapsing remitting MS received high-dose immunosuppressive therapy followed by transplantation of their own stem cells. All but two showed no signs of progression, only three had had a relapse and 19 showed no loss of function, relapse or new MRI lesions.
Web MD
US National Institutes of Health
Stem cells - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 30, 2014 Category: Neurology Source Type: news
Encouraging results from stem cell trial
Interim results from a five year stem cell study suggest the treatment could eventually be an effective way to manage relapsing remitting MS. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 30, 2014 Category: Neurology Source Type: news
Debbie Purdy
The MS Trust was saddened to hear of the death of Debbie Purdy. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 30, 2014 Category: Neurology Source Type: news
Running event sale ends tomorrow
Our early bird registration discounts on the 2015 British 10K London Run and Great North Run end tomorrow. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 30, 2014 Category: Neurology Source Type: news
Debbie Purdy dies
The woman with MS who campaigned to change the law around assisted suicide has died in a hospice in Bradford.
BBC
Guardian
Daily Telegraph
Independent
Daily Mail
New assisted suicide guidelines published - 26 February 2010 (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 29, 2014 Category: Neurology Source Type: news
Wahls Protocol
A video of Dr Terry Wahls talking about her diet and lifestyle approach to managing chronic conditions and the research she is leading. There are a few more cautious comments by neurologists.
MedPage Today
Diet - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 27, 2014 Category: Neurology Source Type: news
Fingolimod (Gilenya) and lymphopenia risk
German and Swedish studies suggest that underweight women and people with a low lymphocyte count when they start treatment with fingolimod (Gilenya) have a higher risk of lymphopenia (a deficiency in white blood cells) and will need careful monitoring.
MedPage Today
Fingolimod (Gilenya) - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 26, 2014 Category: Neurology Source Type: news
MS Trust inputs to consultation process over new NHS funding proposals that may affect MS care in England
More than 300 consultants have written an open letter to NHS England expressing strong concerns over proposed changes in how specialised care is funded in the NHS in England (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 24, 2014 Category: Neurology Source Type: news
2014 - the view from Canada
The Canadian MS Society's review of the year (with links to their news stories throughout the year). Items covered include progressive MS, CCSVI and lifestyle factors.
Canadian MS Society
Latest MS research updates (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 23, 2014 Category: Neurology Source Type: news
Difference in MS in younger people
Two Canadian studies have found that children with MS have smaller brains than their peers due to slower growth and atrophy but that tissue recovery around lesions is greater in paediatric than adult MS.
MS Discovery Forum
Paediatric MS - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 19, 2014 Category: Neurology Source Type: news
Can you help us develop a website for people choosing a disease modifying drug?
Since it was launched in 2004, many people have used MS Decisions to help them choose between the self-injected drugs for relapsing remitting MS. We're just starting on a project to redevelop the website to include the wider range of drugs now available.
Read the full blog. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 19, 2014 Category: Neurology Source Type: news
False information about life insurance for people with MS
We've been made aware that a website called 'Cover4Life' is falsely advertising a life insurance product from 'Your Life Protected' as being promoted by the MS Trust. (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 19, 2014 Category: Neurology Source Type: news
Side effects of Gilenya and Tysabri
Review article includes varicella-zoster infections associated with fingolimod (Gilenya) and antiNMDA antibodies resulting from stopping treatment with natalizumab (Tysabri) .
MedPage Today
Fingolimod (Gilenya) - A to Z of MS
Natalizumab (Tysabri) - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 18, 2014 Category: Neurology Source Type: news
Cannabis e-cigarette
The authorities in France are considering the legality of an e-cigarette that contains cannabidiol - an extract from cannabis. A company is planning to launch the product and suggest it could be used to help people with MS and cancer manage pain, though it is not being launched as a medical device.
Daily Mail
AFP
Cannabis - A to Z of MS (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 16, 2014 Category: Neurology Source Type: news
Athletes with MS
Kadeena Cox, a young sprinter who has recently diagnosed with MS, has been featured on Adrian Chiles' show on Radio 5. They also talked to Trish Deykin, a triathlete with MS.
BBC
Triathlon gold for Trish Deykin - news item, 6 June 2013 (Source: Multiple Sclerosis Trust)
Source: Multiple Sclerosis Trust - December 16, 2014 Category: Neurology Source Type: news
